HIF inhibitor BAY 87-2243, Purity ≥98%

Cat. No.: X24-06-ZQ422

HIF inhibitor BAY 87-2243, Purity ≥98%

Synonym: 1227158-85-1; HIF inhibitor; BAY-87-2243

  • CAS Number: 1227158-85-1
  • Compound CID: 67377767
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
BAY 87-2243, soluble in warmed DMSO and warmed ethanol and insoluble in water, is designed to disrupt the hypoxia-inducible factor (HIF) pathway, aiming to hinder cancer cell survival and adaptation in low-oxygen environments characteristic of tumor growth. It targets HIF-1.
Molecular Weight
525.53
Molecular Formula
C26H26F3N7O2
Targets
HIF-1
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 33 mg/mL (62.79 mM); Water: Insoluble; Warmed ethanol: 8 mg/mL (15.22 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
BAY 87-2243 serves research in tumor biology and hypoxia-related pathologies by delving into the modulation of hypoxia-induced factors.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0